Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Terminated 1Suspended 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 2

Conditions

Stomach Neoplasms 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma 1

Interventions

Paclitaxel 575Carboplatin 521Cisplatin 351Bevacizumab 252pembrolizumab 228Gemcitabine 157Topotecan 128Cyclophosphamide 128liposomal doxorubicin 127olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 81niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 57Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Infusions, Parenteral × Gynecologic × Clear all
NCT03959761 2025-12-19

ICONIC

Hospices Civils de Lyon

Phase 1/2 Completed
22 enrolled
Gynecologic

Ovarian Neoplasms

NCT00889733 2024-03-26

OVHM-01

University Health Network, Toronto

Phase 1/2 Terminated
9 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT01342653 2016-11-21

HIPEC

Hospital General Universitario Gregorio Marañon

Phase 2 Suspended
50 enrolled
GastrointestinalGynecologic

Carcinoma, Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡